rxc004
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Feb 5, 2018 (NCT03447470)
Timeline
Indications
Mechanism of action
PORCN inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04907851 | Phase 2 | Sep 30, 2021 | Redx Pharma Plc |
| NCT04907539 | Phase 2 | Aug 31, 2021 | Redx Pharma Plc |
| NCT03447470 | Phase 1 | Feb 5, 2018 | Redx Pharma Plc |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Redx Pharma Plc | For profit | 3 | 3 | 2 | 2018 |
1 organizations
Page 1 / 1